Oct 19 (Reuters) - Living Cell Technologies Ltd LCT.AX :
* SECURED FUNDING FOR A THIRD CLINICAL TRIAL OF NTCELL IN PARKINSON'S DISEASE
* COMPLETED PLACEMENT RAISING A$3.5 MILLION
Source text for Eikon: ID:nASXbgXbmM Further company coverage: LCT.AX
((Reuters.Briefs@thomsonreuters.com;))